Rapamycin inhibits human adipocyte differentiation in primary culture.
about
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular EffectsThe mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trialsmTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and agingTamoxifen reduces fat mass by boosting reactive oxygen speciesInsulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway.Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo.Inhibition of Adipogenesis by Oligonol through Akt-mTOR Inhibition in 3T3-L1 Adipocytes.15(S)-HETE-induced angiogenesis in adipose tissue is mediated through activation of PI3K/Akt/mTOR signaling pathway.Rapamycin-induced metabolic defects are reversible in both lean and obese miceRapamycin impairs HPD-induced beneficial effects on glucose homeostasis.14-3-3ζ coordinates adipogenesis of visceral fat.Koschei the immortal and anti-aging drugsThe multifaceted role of mTORC1 in the control of lipid metabolismMechanistic target of rapamycin controls homeostasis of adipogenesis.mTOR couples cellular nutrient sensing to organismal metabolic homeostasisIn situ characterization of the mTORC1 during adipogenesis of human adult stem cells on chipRapamycin Modulates Markers of Mitochondrial Biogenesis and Fatty Acid Oxidation in the Adipose Tissue of db/db Mice.Autophagy regulates adipose mass and differentiation in mice.An emerging role of mTOR in lipid biosynthesis.Rapamycin: one drug, many effects.mTOR and the differentiation of mesenchymal stem cells.Role of energy- and nutrient-sensing kinases AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in adipocyte differentiation.Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation.Fucosterol, isolated from Ecklonia stolonifera, inhibits adipogenesis through modulation of FoxO1 pathway in 3T3-L1 adipocytes.Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes.Adipocyte-specific deletion of mTOR inhibits adipose tissue development and causes insulin resistance in mice.Fifty shades of white: Understanding heterogeneity in white adipose stem cells.Chronic leucine supplementation increases body weight and insulin sensitivity in rats on high-fat diet likely by promoting insulin signaling in insulin-target tissues.Dynamic protein pathway activation mapping of adipose-derived stem cell differentiation implicates novel regulators of adipocyte differentiation.Inhibition of preadipocyte differentiation and lipid accumulation by Orengedokuto treatment of 3T3-L1 cultures.High insulin-induced down-regulation of Erk-1/IGF-1R/FGFR-1 signaling is required for oxidative stress-mediated apoptosis of adipose-derived stem cells.Autophagy Maintains the Function of Bone Marrow Mesenchymal Stem Cells to Prevent Estrogen Deficiency-Induced Osteoporosis.mTOR signaling in stem and progenitor cells.
P2860
Q26749011-54ABDC34-4C42-46AB-8479-6A42CA457702Q26751155-B7D95406-D088-49F8-B243-24BE2262A27BQ28081442-C0DB6B24-D5AC-41C6-A7B9-5CB1597FC406Q30370538-70AB3B8A-963B-4D3B-AB36-EC1B37824329Q33480974-BE7E6226-0D54-47A8-9FBA-C1CB1D1A7A5FQ33676236-D50A87D2-E56F-4B37-B656-3C6B258C39B6Q34257057-05BE530D-2A5C-464E-9F6B-6B75BC947A1EQ34384383-D401BDF0-5C66-4CA9-A319-0258471DA1B6Q34461128-8C51B256-A168-4DA6-A8C7-17315F0FA3EBQ35911741-003E04AE-A4FB-4735-B95D-C15AAA96FBB8Q35941573-27874F4B-292F-4AFA-B28B-B6AB2B70776EQ36292001-567811CE-094E-4B37-84E0-DFDDD4D15BE5Q36659049-29DD056B-509A-4D18-A328-56F538DC20CEQ37002663-CF579BCB-35E4-4C3C-82F3-D6704E5623DFQ37097444-A974D2B0-E447-4A23-9BF9-A9871BB1AE39Q37126759-3F3549D1-AA17-4006-9E8E-89CF20B43DD0Q37140838-A5EA621B-8D38-46BF-90B0-E4C05B4057C0Q37403082-96F4E291-9D0F-4210-A900-D594AF646D93Q37641438-76D70937-A7B0-485A-B456-A9FEE991DBFFQ37679469-BF557395-CB83-4B7F-BA3C-F5FC6E557B17Q37885070-4B96616E-1CAD-4F1C-9417-25E5C31A1567Q38106669-53971170-17C1-498C-AD34-444FC904D1AAQ38302018-443F4F31-1BAC-42BE-9F0A-52492160CCF5Q38718870-A96E0BDF-022B-48FD-9A9F-A491E0AEB012Q39468474-923B21EA-DC24-4989-B150-2B3449CDF2D5Q41965455-299170B2-1743-4399-92BB-CB6A3B96CC19Q41994084-1F9BD2EF-A19A-4165-BFB7-42EED53E5907Q42520649-D86C076D-53F0-47BC-A6DB-F883DC5EC806Q42595969-DE02E65E-94D8-42CE-8C7F-BD1E0020C51AQ42810904-ED58BAD7-9E7E-4EA1-8D4A-7C75B524534CQ46895204-5205DA4B-BD2B-42A4-B303-3F3B80C6ADF9Q47154773-9AFC84A2-D109-4E03-9D59-1A394C959C42Q48293926-E4667388-B6C8-4BCC-916D-2144499D6EA8
P2860
Rapamycin inhibits human adipocyte differentiation in primary culture.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Rapamycin inhibits human adipocyte differentiation in primary culture.
@en
type
label
Rapamycin inhibits human adipocyte differentiation in primary culture.
@en
prefLabel
Rapamycin inhibits human adipocyte differentiation in primary culture.
@en
P2093
P2860
P356
P1433
P1476
Rapamycin inhibits human adipocyte differentiation in primary culture.
@en
P2093
P2860
P304
P356
10.1038/OBY.2000.29
P577
2000-05-01T00:00:00Z